Actis exits Chinese diagnostics business Chemclin for $150m

Actis exits Chinese diagnostics business Chemclin for $150m

Ka Kay Lum

03 August, 2018

ActisChina International Capital Corp (CICC)GHL Systems BhdStandard Chartered Private Equity (SCPE)

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.